Fadhéla Bouafia-Sauvy

Early stage follicular lymphoma: what is the clinical impact of the first-line treatment strategy?

Anne-Sophie Michallet, Laure Lebras, Deborah Bauwens et al. · Journal of Hematology & Oncology · 2013 · 37 citations · Full text

Medicine, Oncology, Chemotherapy +13

Chemotherapy with rituximab followed by high‐dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma

Catherine Thiéblemont, Daciana Antal, Laurence Lacotte‐Thierry et al. · Cancer · 2005 · 35 citations · Full text

Medicine, Hematology, Oncology +15

Comparative toxicities of 3 platinum‐containing chemotherapy regimens in relapsed/refractory lymphoma patients

F. Tixier, Florence Ranchon, Aurore Iltis et al. · Hematological Oncology · 2016 · 34 citations

Medicine, Oncology, Pharmacology +14

Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?

Florence Ranchon, Nicolas Vantard, Émilie Hénin et al. · Hematological Oncology · 2017 · 27 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Retreatment with rituximab in 178 patients with relapsed and refractory B-cell lymphomas: a single institution case control study

Anna Johnston, Fadhéla Bouafia-Sauvy, Florence Broussais‐Guillaumot et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2009 · 23 citations

Medicine, Oncology, Pharmacotherapy +15